Long time no see
Release time:
2021-12-23
Long time no see. These four words lingered on the lips for a long time, but they could not say it. Many parting always thought that there would be a next meeting, but they did not realize that this farewell was not for years, but never again.
still remember that day, sunny, classmates young, waved, said goodbye; still remember that day, rainy, octogenarian old man, hoarse, said goodbye. Later, the young man looked at the first snow in the far north, and the old man lay in the ground during the rainy season. Thousands of words turned into unspeakable regrets. I often look at the blue sky and my thoughts are scattered with the wind. It seems that I have a thread ball in my head. I try to figure it out, only to find that the thread head is deeply hidden in the thread ball and cannot be found. I happened to find that the thread was faint and ready to come out. I wanted to pull out the thread with one breath, only to find that the thread was hidden again. There is no way to think clearly about many things, but always want to find the answer, even if the answer is already in my heart.
Many people will say, let go of the past and live the present. However, I always feel that this sentence is not quite correct. It should be to remember the past and create the present. The past is not forgotten, forgetting the past means betrayal, it is because of everything that happened in the past that we are now. At first, I felt that the memory was not good, and I desperately wanted to forget it, but after many years, the past that I didn't want to talk about may turn into a smile on my lips.
Long time no see, whether the ginkgo in the school is falling quietly again, a piece of Huang Chengcheng, the sun shines down from the gap between the ginkgo leaves, forming a halo one by one. Looking at the sun, even in the big cooling weather, the in the mind also feel warm.
Looking out of the window at the same scene of the four seasons now makes people sad and nostalgic. We always have a lot of regrets. We are thinking about changing the past. It seems that the present beauty is no longer beautiful when compared with the past regrets. It seems that the shining pearls are covered with a layer of ash for no matter, which once again enlarges the regrets. Life should not be so dead cycle, do not let today become tomorrow's regret!
Long time no see, look forward to seeing you next time if you can.
(Wang Junxiao)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31